# Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions

> **NCT03226470** · PHASE1 · UNKNOWN · sponsor: **Huazhong University of Science and Technology** · enrollment: 40 (estimated)

## Conditions studied

- Human Papillomavirus-Related Malignant Neoplasm

## Interventions

- **BIOLOGICAL:** T512

## Key facts

- **NCT ID:** NCT03226470
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-10
- **Primary completion:** 2022-02-10
- **Final completion:** 2022-06-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03226470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03226470, "Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03226470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*